Search results for "pharmacology [Excitatory Amino Acid Antagonists]"

showing 10 items of 421 documents

Supplemental material for Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blin…

2019

Supplemental Material for Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial by Hans-Christoph Diener, Peter J Goadsby, Messoud Ashina, Mohammad Al-Mahdi Al-Karagholi, Alexandra Sinclair, Dimos Mitsikostas, Delphine Magis, Patricia Pozo-Rosich, Pablo Irimia Sieira, Miguel JA Làinez, Charly Gaul, Nicholas Silver, Jan Hoffmann, Juana Marin, Eric Liebler, Michel D Ferrari and on behalf of the PREMIUM Study Group in Cephalalgia

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)110306 Endocrinology111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified3. Good health110904 Neurology and Neuromuscular DiseasesNeuroscience
researchProduct

Supplemental material for Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blin…

2019

Supplemental Material for Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial by Hans-Christoph Diener, Peter J Goadsby, Messoud Ashina, Mohammad Al-Mahdi Al-Karagholi, Alexandra Sinclair, Dimos Mitsikostas, Delphine Magis, Patricia Pozo-Rosich, Pablo Irimia Sieira, Miguel JA Làinez, Charly Gaul, Nicholas Silver, Jan Hoffmann, Juana Marin, Eric Liebler, Michel D Ferrari and on behalf of the PREMIUM Study Group in Cephalalgia

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)110306 Endocrinology111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified3. Good health110904 Neurology and Neuromuscular DiseasesNeuroscience
researchProduct

jop-2017-3257-File006 – Supplemental material for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients w…

2018

Supplemental material, jop-2017-3257-File006 for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis by Patricia Gassó, Sergi Mas, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M. Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Salvador Sarró, Anna Mané, Julio Sanjuan, Adrián Llerena, Amalia Lafuente, Jerónimo Saiz-Ruiz, Miguel Bernardo and PEPs Group in Journal of Psychopharmacology

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified110904 Neurology and Neuromuscular Diseases
researchProduct

jop-2017-3257-File005 – Supplemental material for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients w…

2018

Supplemental material, jop-2017-3257-File005 for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis by Patricia Gassó, Sergi Mas, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M. Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Salvador Sarró, Anna Mané, Julio Sanjuan, Adrián Llerena, Amalia Lafuente, Jerónimo Saiz-Ruiz, Miguel Bernardo and PEPs Group in Journal of Psychopharmacology

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified110904 Neurology and Neuromuscular Diseases
researchProduct

sj-pdf-1-smo-10.1177_20503121211019889 – Supplemental material for The efficacy of single suture for exit site wound closure and stabilization of hem…

2021

Supplemental material, sj-pdf-1-smo-10.1177_20503121211019889 for The efficacy of single suture for exit site wound closure and stabilization of hemodialysis central tunneled catheter by Tomasz Porazko, Andrzej Piersiak and Marian Klinger in SAGE Open Medicine

FOS: Veterinary sciences111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 Otorhinolaryngology70706 Veterinary MedicineFOS: Clinical medicinefungi110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

sj-pdf-1-smo-10.1177_20503121211019889 – Supplemental material for The efficacy of single suture for exit site wound closure and stabilization of hem…

2021

Supplemental material, sj-pdf-1-smo-10.1177_20503121211019889 for The efficacy of single suture for exit site wound closure and stabilization of hemodialysis central tunneled catheter by Tomasz Porazko, Andrzej Piersiak and Marian Klinger in SAGE Open Medicine

FOS: Veterinary sciences111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 Otorhinolaryngology70706 Veterinary MedicineFOS: Clinical medicinefungi110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

The catalytic activity of the endoplasmic reticulum-resident protein microsomal epoxide hydrolase towards carcinogens is retained on inversion of its…

1996

Diol epoxides formed by the sequential action of cytochrome P-450 and the microsomal epoxide hydrolase (mEH) in the endoplasmic reticulum (ER) represent an important class of ultimate carcinogenic metabolites of polycyclic aromatic hydrocarbons. The role of the membrane orientation of cytochrome P-450 and mEH relative to each other in this catalytic cascade is not known. Cytochrome P-450 is known to have a type I topology. According to the algorithm of Hartman, Rapoport and Lodish [(1989) Proc. Natl. Acad. Sci. U.S.A. 86, 5786–5790], which allows the prediction of the membrane topology of proteins, mEH should adopt a type II membrane topology. Experimentally, mEH membrane topology has been …

GlycosylationGlycosylation1303 BiochemistryCytochromeStereochemistryMolecular Sequence Data10050 Institute of Pharmacology and Toxicology610 Medicine & healthEndoplasmic ReticulumBiochemistryCatalysis1307 Cell Biologychemistry.chemical_compoundEndoglycosidase H1312 Molecular BiologyAnimalsAmino Acid SequenceBenzopyrenesMolecular BiologyEpoxide HydrolasesbiologyEndoplasmic reticulumCell BiologyIntracellular MembranesRecombinant ProteinsRatsCytosolMembranechemistryMicrosomal epoxide hydrolaseMembrane topologyCOS Cellsbiology.proteinCarcinogensMutagenesis Site-Directed570 Life sciences; biologyResearch Article
researchProduct

Suicidale Vergiftung durch subcutane Injektion eines Gemisches von Parathion und Demeton-O-methylsulfoxid (E 605 MR�)

1970

Es wird uber einen Pall einer suicidalen Vergiftung durch subcutane Injektion der insecticiden Kombination von Parathion (E 605®) mit Demeton-O-methyl-sulfoxid (Metasystox R®) berichtet. Nach einer akuten Phase, die hauptsachlich durch muscarinahnliche Symptome gekennzeichnet war, schritt die Vergiftung bis zu einer peripheren Atemlahmung nach 6 1/2 Tagen fort. Der klinische Verlauf wird unter Berucksichtigung der Toxicitat der Giftstoffe, ihres Resorptionsweges, ihrer Dosis und der durchgefuhrten Behandlung besprochen. Es wird angedeutet, das die kombinierte Toxicitat der Giftstoffe fur den Menschen hoher sein konnte, als nach fruheren Hinweisen zu erwarten war.

Gynecologymedicine.medical_specialtyChemistryHealth Toxicology and MutagenesisPharmacology toxicologymedicineGeneral MedicineToxicologyF�hner-Wielands Sammlung von Vergiftungsf�llen Archiv f�r Toxikologie
researchProduct

3 Todesf�lle durch Intoxikation (Invertseife) oder durch anaphylaktischen Schock (Ro\kastanienextrakt)?

1965

Es wird uber drei todlich verlaufene Zwischenfalle mit einer uberlebenszeit von 21–46 Std nach einer intravenosen Injektion von angeblich 1/8 mg Strophanthin, 2 ml Vitamin B-Komplex und einem Ro\kastanienextrakt (2,5 ml) berichtet. Die Ermittlungsergebnisse, das klinische Bild, die Sektionsbefunde und die feingeweblichen Untersuchungen lassen jedoch eine Invertseifenlosungintoxikation wahrscheinlicher erscheinen. Diese ist moglicherweise dadurch zustande gekommen, da\ statt des Ro\kastanienextraktes eine entsprechende Menge Zephirol in die Spritzen aufgezogen und intravenos appliziert wurde. Beim Fehlen von positiven toxikologischen Befunden mu\te jedoch auch die Moglichkeit einer anaphylak…

Gynecologymedicine.medical_specialtyChemistryHealth Toxicology and MutagenesisPharmacology toxicologymedicineGeneral MedicineToxicologyF�hner-Wielands Sammlung von Vergiftungsf�llen Archiv f�r Toxikologie
researchProduct

Zur Toxikologie des ?-Phenyl-?-�thylglutarimid (Doriden)

1957

Die bisher in der Literatur niedergelegten pharmakologisch-toxikologischen und klinischen Erfahrungen mit Glutethimid („Doriden-CIBA“) werden mitgeteilt und diskutiert. Die Gesamterfahrungen rechtfertigen die Verwendung dieses neuen Arneimittelkorpers als Schlafmittel. Eine Ausnahmestellung gegenuber anderen leicht abbaubaren Schlafmitteln der Barbitursaurereihe wird nicht ersichtlich. Es wird deshalb die Aufnahme von Glutethimid in die Liste der rezeptpflichtigen pharmazeutischen Spezialitaten fur notwendig erachtet. Neben einigen bekannt gewordenen Intoxikationszustanden durch Glutethimid wird uber eigene Beobachtungen bei einer todlich verlaufenen Vergiftung mit dem gleichen Praparat (Ei…

Gynecologymedicine.medical_specialtyChemistryHealth Toxicology and MutagenesisPharmacology toxicologymedicineGeneral MedicineToxicologyF�hner-Wielands Sammlung von Vergiftungsf�llen Archiv f�r Toxikologie
researchProduct